Eniel Gerardo Rolon Resto, DC | |
1330 Exchange St Ste 105, Middlebury, VT 05753-4464 | |
(802) 388-0970 | |
Not Available |
Full Name | Eniel Gerardo Rolon Resto |
---|---|
Gender | Male |
Speciality | Chiropractor |
Location | 1330 Exchange St Ste 105, Middlebury, Vermont |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538890769 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | 3786 (Massachusetts) | Secondary |
111N00000X | Chiropractor | 006.0134191 (Vermont) | Primary |
Provider Name | Middlebury Sport And Spine Plc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1902576069 PECOS PAC ID: 9032508973 Enrollment ID: O20211115000596 |
News Archive
The partnership of two of the biggest companies worldwide could have major implications for healthcare in the future, particularly for those living in rural or remote communities.
GfK Healthcare's Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients' attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.
Current users of menopausal hormone therapy (MHT) are more than twice as likely than non-users to develop lower gastrointestinal bleeding and ischemic colitis, especially if they use the therapy for longer durations, according to a study at Digestive Disease Week 2015.
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Orgenesis SPRL, a subsidiary of Orgenesis Inc., a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a €2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Eniel Gerardo Rolon Resto, DC 152 Allen Rd Unit 215, South Burlington, VT 05403-3804 Ph: (787) 216-5000 | Eniel Gerardo Rolon Resto, DC 1330 Exchange St Ste 105, Middlebury, VT 05753-4464 Ph: (802) 388-0970 |
News Archive
The partnership of two of the biggest companies worldwide could have major implications for healthcare in the future, particularly for those living in rural or remote communities.
GfK Healthcare's Roper Global Diabetes Programme, the definitive global perspective on diabetes, announced today the launch of its enhanced 2009/2010 Western Europe Patient Study. Offering a holistic perspective of the diabetes patient across five European countries, with robust insights into patients' attitudes and behaviors towards treatments, testing and lifestyles, the study now makes available to marketers greater reporting frequency and focus across a variety of broad-based and niche diabetes patient groups.
Current users of menopausal hormone therapy (MHT) are more than twice as likely than non-users to develop lower gastrointestinal bleeding and ischemic colitis, especially if they use the therapy for longer durations, according to a study at Digestive Disease Week 2015.
GW Cancer Research Team in the Department of Biochemistry and Molecular Biology, in the School of Medicine and Health Sciences, published a study that is the first of its kind to use mRNA sequencing to look at the expression of genome, at a unprecedented resolution at the current time, in three types of breast cancer.
Orgenesis SPRL, a subsidiary of Orgenesis Inc., a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a €2.015 million support program for the research and development of a potential cure for Type 1 Diabetes.
› Verified 8 days ago
Dr. Caitlin Bone, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1330 Exchange St Ste 105, Middlebury, VT 05753 Phone: 802-388-0970 | |
Integrated Medicine: Chiropractic Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1641 Route 7 S, Middlebury, VT 05753 Phone: 802-458-0488 Fax: 802-458-0489 | |
Peak Family Wellness Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1330 Exchange St Ste 105, Middlebury, VT 05753 Phone: 802-388-0970 | |
Dr. Mary Kraus, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1330 Exchange St Ste 105, Middlebury, VT 05753 Phone: 802-388-0970 | |
James Mcdaniel, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1330 Exchange St, Ste 105, Middlebury, VT 05753 Phone: 802-388-0970 | |
Dr. Erik Stephen Vose, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1330 Exchange St, Suite 105, Middlebury, VT 05753 Phone: 617-694-5256 Fax: 802-388-0917 | |
Vose Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 99 Maple St Ste 11a, Middlebury, VT 05753 Phone: 617-694-5256 |